Conavi Medical

Conavi Medical focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enabling synchronized and co-registered imaging of coronary arteries. The Novasight Hybrid System has received 510(k) clearance from the U.S. Food and Drug Administration, as well as regulatory approvals for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labour and Welfare.